The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1664
November 28, 2022
View Complete Issue         Table of Contents 2019 
Issue 1664
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Antiviral Drugs for Influenza for 2022-2023
November 28, 2022 (Issue: 1664)
Influenza is generally a self-limited illness, but complications such as pneumonia, respiratory failure, and death can occur, especially in patients at increased risk for influenza complications (see Table 1). Antiviral drugs recommended for...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1664
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.